Nissha Acquired U.S.-based Medical Devices Contract Manufacturer
June 27, 2018
Nissha Co., Ltd.
Nissha Co., Ltd. has acquired as subsidiaries of its Medical Technologies segment Sequel Special Products, LLC, engaging in contract manufacturing of medical devices, and its affiliated company RSS Design, LLC, engaging in the development and design of medical devices. The share acquisition took place as of June 25, 2018, through the Nissha consolidated subsidiary, Graphic Controls Group.
Nissha introduced the Medical Technologies segment and achieved full-scale entry into the medical devices market in September 2016, with the acquisition as a subsidiary of U.S.-based medical devices manufacturer, Graphic Controls Group. Offerings at present focus on medical electrodes, medical surgical devices, and other products for cardiology, which are highly related to Nissha’s core technologies of “Patterning”, “Coating”, “Lamination”, “Molding”, and “Patterning”. These are provided in global contract manufacturing services for major medical devices manufacturers, and produced and distributed as a proprietary brand for hospitals.
Through these business models, Medical Technologies aims to extend our capabilities such as product development and design, and enrich its lineup of distinctive products toward sustainable growth.
With major medical device manufactures increasingly focusing on R&D and marketing activities and preferring to outsource the manufacturing process, the Medical Technologies segment promotes the expansion of contract design and manufacturing services as a main growth strategy. Its facilities include innovation centers for design & development activities and production centers producing diagnostic sensing devices, electro-surgical devices, catheter guide wires, and other medical devices and surgical instruments for minimally invasive surgery.*1 This acquisition will provide the Medical Technologies segment with new sales channels in contract manufacturing, increased production capacity, and expanded product development and design functions to improve its value chain from development to production to sales.
Sequel products are currently not produced or distributed in Japan.
*1: Medical examination and treatment procedures that minimize the physical risk for the patient
Nissha introduced the Medical Technologies segment and achieved full-scale entry into the medical devices market in September 2016, with the acquisition as a subsidiary of U.S.-based medical devices manufacturer, Graphic Controls Group. Offerings at present focus on medical electrodes, medical surgical devices, and other products for cardiology, which are highly related to Nissha’s core technologies of “Patterning”, “Coating”, “Lamination”, “Molding”, and “Patterning”. These are provided in global contract manufacturing services for major medical devices manufacturers, and produced and distributed as a proprietary brand for hospitals.
Through these business models, Medical Technologies aims to extend our capabilities such as product development and design, and enrich its lineup of distinctive products toward sustainable growth.
With major medical device manufactures increasingly focusing on R&D and marketing activities and preferring to outsource the manufacturing process, the Medical Technologies segment promotes the expansion of contract design and manufacturing services as a main growth strategy. Its facilities include innovation centers for design & development activities and production centers producing diagnostic sensing devices, electro-surgical devices, catheter guide wires, and other medical devices and surgical instruments for minimally invasive surgery.*1 This acquisition will provide the Medical Technologies segment with new sales channels in contract manufacturing, increased production capacity, and expanded product development and design functions to improve its value chain from development to production to sales.
Sequel products are currently not produced or distributed in Japan.
*1: Medical examination and treatment procedures that minimize the physical risk for the patient
Outline of Sequel
Trade name | Sequel Special Products, LLC |
---|---|
Location | 1 Hillside Drive, Wolcott, CT 06716, U.S.A. |
Representative | Scott Debisschop |
Founded | 1994 |
Business outline | Contract manufacturing of surgical instruments for minimally invasive surgery and orthopedics |
Net sales | USD 23,500,000 (approx. JPY 2,585,000,000, fiscal year ended December 2017) Based on an exchange rate of USD 1 = JPY 110 |
Website | http://www.sequelmedical.com/ |
Outline of RSS
Trade name | RSS Design, LLC |
---|---|
Location | 1 Hillside Drive, Wolcott, CT 06716, U.S.A. |
Representative | Jeff Radziunas |
Founded | 2013 |
Business outline | Design and prototyping of medical devices |
Net sales | USD 1,900,000 (approx. JPY , fiscal year ended December 2017) Based on an exchange rate of USD 1 = JPY 110 |
Outline of Graphic Controls Group
Location | 400 Exchange Street, Buffalo, NY 14204, U.S.A. |
---|---|
Representative | Sam Heleba, President and CEO Senior Vice President, General Manager of Medical Technologies Business Unit, Nissha Co., Ltd. |
Founded | 1909 |
employees | 1,072 (Graphic Controls Group consolidated, as of March 31, 2018) |
Business outline | Production and sales of medical devices and business media |
Net sales | USD 163,152thousand (Graphic Controls Group consolidated, fiscal year ended December 2017) |
Outlook for the Future
The impact of the acquisition on Nissha’s consolidated business results is expected to be minor. Prompt notification will be made should the need arise to revise forecasts or disclose other matters.
- The content of the web is information at press time, may change thereafter without notice. Due to risks and uncertainties, predictions may differ from actual results. Please be forewarned.
- "Nissha" is a generic name of Nissha Co., Ltd. and "Nissha Group" is a Nissha Co., Ltd. and its group companies.
- "Nissha" is a generic name of Nissha Co., Ltd. and "Nissha Group" is a Nissha Co., Ltd. and its group companies.